Katherine R. Calvo, Ph.D. - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, ... ... Calvo KR, et al. Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone. Leukemia & Lymphoma. 1-10. PMID 27687480 DOI: 10.1080/10428194.2016.1214953  0.88
2016 Cohen JI, Dropulic L, Hsu AP, Zerbe CS, Krogmann T, Dowdell K, Hornung RL, Lovell J, Hardy N, Hickstein D, Cowen EW, Calvo KR, Pittaluga S, Holland SM. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27169477 DOI: 10.1093/cid/ciw160  0.88
2016 Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. The Journal of Allergy and Clinical Immunology. PMID 27130863 DOI: 10.1016/j.jaci.2016.03.016  0.88
2016 Kuehn HS, Boisson B, Cunningham-Rundles C, Reichenbach J, Stray-Pedersen A, Gelfand EW, Maffucci P, Pierce KR, Abbott JK, Voelkerding KV, South ST, Augustine NH, Bush JS, Dolen WK, Wray BB, ... ... Calvo KR, et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. The New England Journal of Medicine. 374: 1032-1043. PMID 26981933 DOI: 10.1056/NEJMoa1512234  0.88
2016 Skarzynski M, Niemann CU, Lee YS, Martyr S, Maric I, Salem D, Stetler-Stevenson M, Marti GE, Calvo KR, Yuan C, Valdez J, Soto S, Farooqui MZ, Herman SE, Wiestner A. Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 22: 86-95. PMID 26283682 DOI: 10.1158/1078-0432.CCR-15-1304  0.88
2015 Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, ... ... Calvo KR, et al. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: A prospective study using functional and morphologic imaging. Leukemia & Lymphoma. 1-23. PMID 26690712 DOI: 10.3109/10428194.2015.1090572  0.88
2015 Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Jones J, Wong DH, et al. Disruption of in vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib - findings from an investigator initiated phase 2 study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26660519 DOI: 10.1158/1078-0432.CCR-15-1965  0.88
2015 Wang W, Corrigan-Cummins M, Barber EA, Saleh LM, Zingone A, Ghafoor A, Costello R, Zhang Y, Kurlander RJ, Korde N, Roccaro AM, Ghobrial IM, Landgren O, Calvo KR. Aberrant Level of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression. The Journal of Molecular Diagnostics : Jmd. PMID 26433312 DOI: 10.1016/j.jmoldx.2015.06.006  0.88
2015 Landgren O, Shim YK, Michalek J, Costello R, Burton D, Ketchum N, Calvo KR, Caporaso N, Raveche E, Middleton D, Marti G, Vogt RF. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study. Jama Oncology. PMID 26335650 DOI: 10.1001/jamaoncol.2015.2938  0.88
2015 Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, ... ... Calvo KR, et al. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma. Jama Oncology. PMID 26181891 DOI: 10.1001/jamaoncol.2015.2010  0.88
2015 Niemela J, Kuehn HS, Kelly C, Zhang M, Davies J, Melendez J, Dreiling J, Kleiner D, Calvo K, Oliveira JB, Rosenzweig SD. Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings. Journal of Clinical Immunology. 35: 348-55. PMID 25814141 DOI: 10.1007/s10875-015-0150-8  0.88
2015 Lozier JN, Calvo KR. Effect of viral decontamination measures on Wright-stained blood smears. Blood. 125: 1350-1. PMID 25700425 DOI: 10.1182/blood-2014-12-614701  0.88
2015 Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, Rao VK. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 125: 2753-8. PMID 25691160 DOI: 10.1182/blood-2014-11-567917  0.88
2015 Montezuma-Rusca JM, Moir S, Kardava L, Buckner CM, Louie A, Kim LJ, Santich BH, Wang W, Fankuchen OR, Diaz G, Daub JR, Rosenzweig SD, Chun TW, Li Y, Braylan RC, ... Calvo KR, et al. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals. Journal of Immunology (Baltimore, Md. : 1950). 194: 2561-8. PMID 25681347 DOI: 10.4049/jimmunol.1402424  0.88
2015 Goswami M, McGowan KS, Lu K, Jain N, Candia J, Hensel NF, Tang J, Calvo KR, Battiwalla M, Barrett AJ, Hourigan CS. A multigene array for measurable residual disease detection in AML patients undergoing SCT. Bone Marrow Transplantation. 50: 642-51. PMID 25665046 DOI: 10.1038/bmt.2014.326  0.88
2015 McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, ... ... Calvo KR, et al. Chromothriptic cure of WHIM syndrome. Cell. 160: 686-99. PMID 25662009 DOI: 10.1016/j.cell.2015.01.014  0.88
2015 Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, ... ... Calvo KR, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. The Lancet. Oncology. 16: 169-76. PMID 25555420 DOI: 10.1016/S1470-2045(14)71182-9  0.88
2015 Ganapathi KA, Townsley DM, Hsu AP, Arthur DC, Zerbe CS, Cuellar-Rodriguez J, Hickstein DD, Rosenzweig SD, Braylan RC, Young NS, Holland SM, Calvo KR. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 125: 56-70. PMID 25359990 DOI: 10.1182/blood-2014-06-580340  0.88
2015 Manasanch EE, Salem DA, Yuan CM, Tageja N, Bhutani M, Kwok M, Kazandjian D, Carter G, Steinberg SM, Zuchlinski D, Mulquin M, Calvo K, Maric I, Roschewski M, Korde N, et al. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: Influence of biopsy site and anticoagulation method Leukemia and Lymphoma. 56: 1416-1424. DOI: 10.3109/10428194.2014.955020  0.88
2015 Ganapathi KA, Schafernak KT, Rao VK, Calvo KR. Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases Journal of Hematopathology. 8: 159-167. DOI: 10.1007/s12308-015-0250-7  0.88
2014 Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, Hughes T, Hakim F, Cole K, Parta M, Freeman A, Holland SM, Hickstein DD. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1940-8. PMID 25111582 DOI: 10.1016/j.bbmt.2014.08.004  0.88
2014 Zingone A, Wang W, Corrigan-Cummins M, Wu SP, Plyler R, Korde N, Kwok M, Manasanch EE, Tageja N, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Roschewski M, Zhang Y, ... ... Calvo KR, et al. Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease. Cytokine. 69: 294-7. PMID 25043675 DOI: 10.1016/j.cyto.2014.05.017  0.88
2014 Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, Wolfe L, Memoli MJ, He M, Vega H, Kim LJ, Huang Y, Hussein N, Nievas E, Mitchell R, Garofalo M, ... ... Calvo KR, et al. Glycosylation, hypogammaglobulinemia, and resistance to viral infections. The New England Journal of Medicine. 370: 1615-25. PMID 24716661 DOI: 10.1056/NEJMoa1302846  0.88
2014 Herman SE, Niemann CU, Farooqui M, Jones J, Mustafa RZ, Lipsky A, Saba N, Martyr S, Soto S, Valdez J, Gyamfi JA, Maric I, Calvo KR, Pedersen LB, Geisler CH, et al. Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia. 28: 2188-96. PMID 24699307 DOI: 10.1038/leu.2014.122  0.88
2014 Korde N, Carlsten M, Lee MJ, Minter A, Tan E, Kwok M, Manasanch E, Bhutani M, Tageja N, Roschewski M, Zingone A, Costello R, Mulquin M, Zuchlinski D, Maric I, ... Calvo KR, et al. A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma. Haematologica. 99: e81-3. PMID 24658821 DOI: 10.3324/haematol.2013.103085  0.88
2014 Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, ... ... Calvo KR, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. The New England Journal of Medicine. 370: 911-20. PMID 24552284 DOI: 10.1056/NEJMoa1307361  0.88
2014 McDermott DH, Liu Q, Velez D, Lopez L, Anaya-O'Brien S, Ulrick J, Kwatemaa N, Starling J, Fleisher TA, Priel DA, Merideth MA, Giuntoli RL, Evbuomwan MO, Littel P, Marquesen MM, ... ... Calvo KR, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 123: 2308-16. PMID 24523241 DOI: 10.1182/blood-2013-09-527226  0.88
2014 Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, et al. Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases Leukemia Research. 38: 371-376. PMID 24462038 DOI: 10.1016/j.leukres.2013.12.007  0.88
2014 Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 123: 1818-25. PMID 24345753 DOI: 10.1182/blood-2013-10-534743  0.88
2014 Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 123: 809-21. PMID 24227816 DOI: 10.1182/blood-2013-07-515528  0.88
2014 Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, ... Calvo KR, et al. Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia. 28: 413-6. PMID 24045500 DOI: 10.1038/leu.2013.268  0.88
2014 Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma Leukemia and Lymphoma. 55: 1402-1403. PMID 23915224 DOI: 10.3109/10428194.2013.831091  0.88
2013 Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M. Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6873-81. PMID 24277451 DOI: 10.1158/1078-0432.CCR-13-1752  0.88
2013 Bat T, Steinberg SM, Childs R, Calvo KR, Barrett AJ, Battiwalla M, Baird K, Zhang D, Pulanic D, Dunbar CE, Pavletic SZ. Active thrombopoiesis is associated with worse severity and activity of chronic GVHD. Bone Marrow Transplantation. 48: 1569-73. PMID 23832091 DOI: 10.1038/bmt.2013.95  0.88
2013 Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 964-72. PMID 23531552 DOI: 10.1038/mt.2013.34  0.88
2013 Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC. Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Molecular & Cellular Proteomics : McP. 12: 1621-31. PMID 23449826 DOI: 10.1074/mcp.M112.026427  0.88
2013 Shao H, Calvo KR, Grönborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leukemia Research. 37: 401-9. PMID 23347903 DOI: 10.1016/j.leukres.2012.11.021  0.88
2013 Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, et al. Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study. Leukemia & Lymphoma. 54: 2215-8. PMID 23311294 DOI: 10.3109/10428194.2013.764419  0.88
2013 Lee JM, Hays JL, Noonan AM, Squires J, Minasian L, Annunziata C, Wood BJ, Yu M, Calvo KR, Houston N, Azad N, Kohn EC. Feasibility and safety of sequential research-related tumor core biopsies in clinical trials. Cancer. 119: 1357-64. PMID 23280317 DOI: 10.1002/cncr.27916  0.88
2013 Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE. Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion. 53: 1201-4. PMID 23043309 DOI: 10.1111/j.1537-2995.2012.03918.x  0.88
2012 Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. The Journal of Clinical Investigation. 122: 3692-704. PMID 22996659 DOI: 10.1172/JCI61623  0.88
2012 Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. The New England Journal of Medicine. 367: 11-9. PMID 22762314 DOI: 10.1056/NEJMoa1200931  0.88
2012 Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. American Journal of Hematology. 87: 916-22. PMID 22473867 DOI: 10.1002/ajh.23174  0.88
2012 Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 119: 3330-2. PMID 22210875 DOI: 10.1182/blood-2011-09-379339  0.88
2012 Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 97: 586-94. PMID 22102710 DOI: 10.3324/haematol.2011.048132  0.88
2012 Calvo KR, Hickstein DD, Holland SM. MonoMAC and GATA2 deficiency: Overlapping clinical and pathological features with aplastic anemia and idiopathic CD4 + lymphocytopenia Haematologica. 97: 12-13. DOI: 10.3324/haematol.2012.063396  0.88
2011 Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, Hsu AP, Zerbe CS, Calvo KR, Wilder J, Kurlander R, Olivier KN, Holland SM, Hickstein DD. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood. 118: 3715-20. PMID 21816832 DOI: 10.1182/blood-2011-06-365049  0.88
2011 Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 118: 2653-5. PMID 21670465 DOI: 10.1182/blood-2011-05-356352  0.88
2011 Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 96: 1221-5. PMID 21508125 DOI: 10.3324/haematol.2011.041152  0.88
2011 Maric I, Calvo KR. Mastocytosis: the new differential diagnosis of CD30-positive neoplasms. Leukemia & Lymphoma. 52: 732-3. PMID 21463113 DOI: 10.3109/10428194.2011.561389  0.88
2011 Calvo KR, Landgren O, Roccaro AM, Ghobrial IM. Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma. Seminars in Hematology. 48: 39-45. PMID 21232657 DOI: 10.1053/j.seminhematol.2010.11.007  0.88
2011 Calvo KR, McCoy CS, Stetler-Stevenson M. Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods in Molecular Biology (Clifton, N.J.). 699: 295-316. PMID 21116989 DOI: 10.1007/978-1-61737-950-5_14  0.88
2010 Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC. Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2 Clinical Cancer Research. 16: 664-672. PMID 20068097 DOI: 10.1158/1078-0432.CCR-09-2308  0.88
2009 Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z. Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2361-72. PMID 19318490 DOI: 10.1158/1078-0432.CCR-08-1011  0.88
2008 Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood. 112: 3818-26. PMID 18682601 DOI: 10.1182/blood-2008-02-138933  0.88
2007 Kurup SK, Levy-Clarke G, Calvo KR, Jaffe ES, Nussenblatt RB, Chan CC. Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids. Clinical & Experimental Ophthalmology. 35: 468-72. PMID 17651253 DOI: 10.1111/j.1442-9071.2007.01517.x  0.88
2006 Ingkanisorn WP, Paterson DI, Calvo KR, Rosing DR, Schwartzentruber DJ, Fuisz AR, Arai AE. Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 8: 353-60. PMID 16669178 DOI: 10.1080/10976640500452000  0.88
2006 Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nature Methods. 3: 287-93. PMID 16554834 DOI: 10.1038/nmeth865  0.88
2006 Mundinger GS, Espina V, Liotta LA, Petricoin EF, Calvo KR. Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray Targeted Oncology. 1: 151-167. DOI: 10.1007/s11523-006-0025-2  0.88
2005 Calvo KR, Liotta LA, Petricoin EF. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Bioscience Reports. 25: 107-25. PMID 16222423 DOI: 10.1007/s10540-005-2851-3  0.88
2004 Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Advances in Anatomic Pathology. 11: 227-38. PMID 15322489 DOI: 10.1097/01.pap.0000138144.11635.f8  0.88
2002 Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 21: 4247-56. PMID 12082612 DOI: 10.1038/sj.onc.1205516  0.88
2001 Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13120-5. PMID 11687616 DOI: 10.1073/pnas.231115398  0.88
2000 Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Molecular and Cellular Biology. 20: 3274-85. PMID 10757811 DOI: 10.1128/MCB.20.9.3274-3285.2000  0.88
1999 Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 18: 8033-43. PMID 10637514 DOI: 10.1038/sj.onc.1203377  0.88
1997 Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proceedings of the National Academy of Sciences of the United States of America. 94: 14553-8. PMID 9405651 DOI: 10.1073/pnas.94.26.14553  0.88
1996 Calvo KR, Babior BM, Gottlieb RA. Transglutamination of a single major 43 kDa protein in the cytoskeleton of apoptotic cells from the human T lymphoblastoid line, Jurkat Journal of Investigative Medicine. 44: 109A.  0.88
Show low-probability matches.